At CFO (Boardroom Media) we track over 1,000,000 startups and over 5,000,000 people who hold key positions in these companies. We use this directory of startups to highlight top employees, founders and board members we think deserve more appreciation than they are currently getting.
This list showcases the top Canada based CFO’ operating in the Pharmaceutical space. If you think a CFO’ is missing from this list, feel free to contact our editor on [email protected]
The individuals on this list have been included because of exceptional performance in one of the following categories:
- Innovation – Operating as a key part in an extremely innovative business or startup.
- Growth – Operating as a key figure in the growth and upscale of a market leading business or startup.
- Management – Showing exceptional management skills.
- Societal impact – Putting their business on the map for their positive societal or environmental impact.
Our Data – We source our data from OSINT (open source intelligence) and public directories such as Crunchbase, SemRush and many more. The data from these sources should be treated with a degree of caution and verified yourself.
Chief Financial Officer of Aurin Biotech
Nizar Bharmal is a renowned Certified General Accountant with over 30 years of well-merited accomplishments in his field. He was granted the professional designation of CGA in 1980. Early in his career he worked in the real estate development and investment field. From 1982 until 1985 Mr. Bharmal was Manager of the Bomarc Group, a management company providing services for reporting companies. In 1985, Mr. Bharmal passed the Canadian Securities Course with honors and founded Nizar Bharmal Inc. as a public practice dedicated to providing an array of accounting services, including Canadian and US taxation, financial consulting and corporate management for reporting companies. During his career, he has served as CEO and CFO for several publicly listed companies, where he has gained deep insight into both operations and regulatory affairs. Mr. Bharmal’s extensive association with and commitment to local business communities has resulted in admiration and confidence from many of his colleagues.
Follow Nizar Bharmal:
About ArcPacific Resources, Aurin Biotech: Aurin Biotech Inc. is a private company established to advance the development of a remarkable collection of small molecules.
Vasco Larcina. CPA
Chief Financial Officer of Lumira Ventures
Contributing over 20 years of senior financial management and audit experience, Vasco is a key member of senior management working closely with our investment team, external auditors and other finance professionals and acting as the primary point of contact for our limited partners. Having worked through the re-organization of the company and the disposition of the retail segment of the business, Vasco now focuses on the growth of the institutional fund management business, the streamlining of finance and legal operations and external reporting to our limited partners. Responsible for the financial management of Lumira Ventures and the investment funds it manages, Vasco oversees financial and legal operations, ensuring that the appropriate controls are in place to manage the activities of Lumira Ventures and its managed funds through the strategic evaluation, development and implementation of financial policies, systems and procedures developed in consideration of external reporting, risk and governance as well as regulatory and tax compliance. Prior to joining Lumira Ventures, Vasco worked as an external auditor with KPMG and has gained internal audit and operational audit experience with a regulated public utility where he provided the internal control input for a major customer information system development project.
Follow Vasco Larcina. CPA:
About Lumira Ventures: Canada’s leading health care & life sciences venture capital firm with a 30-year reputation building companies across North America.
Partner and Chief Financial Officer of NuChem Sciences
Patrick Montpetit has over fifteen years of experience in senior financial management positions. He is a chartered accountant, specializing in corporate finance and has extensive experience in the life sciences and biopharmaceutical industries. Prior to joining Immunotec, Mr. Montpetit served as Vice-President, Finance and Chief Financial Officer of Bioniche Life Sciences Inc. and Director of Finance, Administration, Commercial Agreements and Alliances with DSM Biologics Inc. His professional experience includes serving as Chairman of the Quebec Biotechnology Association and Director of the Montreal InVivo organization.
Follow Patrick Montpetit:
About NuChem Sciences: NuChem Sciences is a drug discovery in chemistry contract research organization (CRO) located in Montréal.
Interim CEO & CFO of Zomedica
Shameze Rampertab is the Interim CEO at Zomedica.
Follow Shameze Rampertab:
About Asensus Surgical, Zomedica: Zomedica Pharmaceuticals is a veterinary pharmaceutical company.
Vice President & CFO of Renaissance Acquisition Holdings
Christine Woolgar has over 25 years of experience in financial management of which 15 years were spent in the pharmaceutical industry. Most recently, she held the position of Vice President and CFO at Sandoz Canada Inc., previously Sabex, from 1995 until 2009. Prior to joining Sabex, she was a senior audit manager at Ernst and Young with a broad-based client consulting practice. Ms. Woolgar received her Bachelors Degree in Accounting from Université du Québec à Montréal and holds the professional designation of Chartered Accountant.
Follow Christine Woolgar:
About Renaissance Acquisition Holdings: specialty and generics business.
CFO of HealthTech Connex
Mr. Buckett brings with him over twelve years of finance and project management experience working for private and publicly listed companies in the UK, US, and Canada. Mr. Buckett began his career with KPMG in London and then in Vancouver as Senior Auditor, later joining Ernst & Young as an audit department Manager. Most recently he was Vice President of Finance at Wurldtech Security Technologies, Inc. His responsibilities have included internal control and governance policy, the implementation of Sarbanes-Oxley in a number of SEC registrants, and managing the reporting requirements of a range of private and public companies.
Follow Simon Buckett:
About HealthTech Connex: HealthTech Connex focuses on technology-based innovations for health improvements and outcomes.
CFO of Glycovax Pharma
Follow Yacine Amrani:
About Glycovax Pharma, Massfilter, Travoom: Glycovax Pharma focuses on developing nano-medicines to treat cancers and other diseases.
CFO of Aequus Pharmaceuticals
Fehr is the Principal at Fehr & Associates, and has held a number of senior level positions including having served as CFO of Carrus Capital Corporation (formerly BioWest Therapeutic Inc.), Global Minerals Ltd., and other companies listed on the TSX. During the course of her management and consulting career, Ms. Fehr has led a number of companies through significant change and corporate milestones such as public listing applications, mergers and acquisitions, as well as strategic planning and execution. Ms. Fehr is also an active volunteer in the community. Since 2013, she has been Treasurer and a Director for the Boys and Girls Clubs of South Coast BC.
Follow Ann Fehr:
About Aequus Pharmaceuticals: Aequus Pharmaceuticals is a pharmaceutical company that focuses on therapeutic areas, including neurology, ophthalmology, and transplant.
Chief Financial Officer & Senior Vice President, Finance of Highland Therapeutics
Follow Nelson Isabel:
About Highland Therapeutics: Highland Therapeutics is a specialty pharmaceutical company that uses technologies to optimize the delivery of previously approved drugs.
VP & CFO of Ceapro
Follow Branko Jankovic:
About Ceapro: Ceapro is into developing functionally active ingredients derived from oats and renewable plant resources for healthcare and cosmetic needs.
CFO of InMed Pharmaceuticals
Bruce Colwill is the Chief Financial Officer at InMed Pharmaceuticals.
Follow Bruce Colwill:
About InMed Pharmaceuticals: InMed Pharmaceuticals is a clinical-stage company developing cannabinoid-based pharmaceutical drug candidates.
Chief Financial Officer of NervGen Pharma
Follow Bill Adams:
About NervGen Pharma: NervGen Pharma is a medicine company dedicated to creating solutions for the treatment of nerve damage and neurodegenerative diseases.
CEO and Interim CFO of The Green Organic Dutchman Holdings
Sean Bovingdon is the CEO and Interim CFO at The Green Organic Dutchman Holdings.
Follow Sean Bovingdon:
About The Green Organic Dutchman Holdings: TGOD grows high quality, organic cannabis with sustainable, all-natural principles. TGOD has a funded capacity of 116,000 kg.